Suppression of choline-deficient diet-induced hepatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio(N-beta-hydroxyethyl)- acetamide and di(2-ethylhexyl)phthalate.

Many hypolipidemic peroxisome proliferators have been shown to induce liver tumors in rats after long-term feeding. In short-term assays, however, some of them prevent the development of gamma-glutamyl transpeptidase-positive foci, the putative preneoplastic lesions, in the liver of carcinogen-initiated rats and inhibit the promoting effect of a choline-deficient (CD) diet on these lesions. The CD diet-induced lipid peroxidation in the liver has been implicated as one of the underlying mechanisms of the promoting effect. In the present study, the effects of 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio(N-beta-hydroxyethyl)acetamid e (BR931) and di(2-ethylhexyl)phthalate (DEHP) on CD diet-induced liver membrane lipid peroxidation were investigated by determining the extents of conjugated diene formation. No evidence of lipid peroxidation was detected in the microsomal lipids of the liver after administration of BR931 or DEHP at concentrations of 0.16% and 1%, respectively, for 1, 2, and 4 wk. When added to a CD diet, both BR931 and DEHP effectively protected against the diet-induced lipid peroxidation. There was an increase in cellular glutathione levels after 4 wk and an increase in catalase activity after 2 wk in the liver of rats fed BR931 or DEHP. The levels of activity of the glutathione peroxidases and glutathione-s-transferase were significantly reduced. The results suggest that, in the acute stage, hypolipidemic peroxisome proliferator-induced effects of excess production of H2O2 and potential lipid peroxidation are balanced by stimulation of some cellular detoxifying systems. The inhibition of lipid peroxidation by hypolipidemic peroxisome proliferators may account for their inhibitory effects on the CD diet-induced promotion of preneoplastic foci.

[1]  G. Williams,et al.  Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital. , 1985, Cancer research.

[2]  A. Demetris,et al.  Lipid peroxidation of liver microsome membranes induced by choline-deficient diets and its relationship to the diet-induced promotion of the induction of gamma-glutamyltranspeptidase-positive foci. , 1985, Cancer research.

[3]  S. Goel,et al.  Increased lipid peroxidation in the rat liver following induction of peroxisome proliferation , 1985 .

[4]  G. Williams,et al.  Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide. , 1985, Toxicology and applied pharmacology.

[5]  W. H. Lawrence,et al.  Mutagenicity evaluation of phthalic acid esters and metabolites in Salmonella typhimurium cultures. , 1985, Journal of toxicology and environmental health.

[6]  J. Swenberg,et al.  Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate. , 1985, Carcinogenesis.

[7]  J. Reddy,et al.  DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Rushmore,et al.  Rapid lipid peroxidation in the nuclear fraction of rat liver induced by a diet deficient in choline and methionine. , 1984, Cancer letters.

[9]  T. Smith-Oliver,et al.  Lack of genotoxic activity of di(2-ethylhexyl)phthalate (DEHP) in rat and human hepatocytes. , 1984, Carcinogenesis.

[10]  J. Reddy,et al.  Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator. , 1984, Biochemical and biophysical research communications.

[11]  D. Touchard,et al.  Impairment of hepatic glutathione S-transferase activity as a cause of reduced biliary sulfobromophthalein excretion in clofibrate-treated rats. , 1984, Biochemical pharmacology.

[12]  H. Pitot,et al.  Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella. , 1984, Cancer letters.

[13]  K. Linnainmaa.  Induction of sister chromatid exchanges by the peroxisome proliferators 2,4-D, MCPA, and clofibrate in vivo and in vitro. , 1984, Carcinogenesis.

[14]  M. Rao,et al.  Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. , 1984, Cancer research.

[15]  D. Kornbrust,et al.  Effect of di(2-ethylhexyl) phthalate on DNA repair and lipid peroxidation in rat hepatocytes and on metabolic cooperation in Chinese hamster V-79 cells. , 1984, Journal of toxicology and environmental health.

[16]  P. Bentley,et al.  Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liver. , 1984, Carcinogenesis.

[17]  R. O. Recknagel,et al.  Spectrophotometric detection of lipid conjugated dienes. , 1984, Methods in enzymology.

[18]  A. Deangelo,et al.  Inhibition of development of preneoplastic lesions in the livers of rats fed a weakly carcinogenic environmental contaminant. , 1983, Cancer letters.

[19]  B. Lombardi,et al.  Modulation of tumor promotion in liver carcinogenesis. , 1983, Environmental health perspectives.

[20]  S. Haworth,et al.  Evaluation of di-(2-ethylhexyl)phthalate and its major metabolites in the Ames test and L5178Y mouse lymphoma mutagenicity assay. , 1983, Environmental mutagenesis.

[21]  J. F. Douglas,et al.  Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute. , 1982, Environmental health perspectives.

[22]  R. Rubin,et al.  Assessment of the mutagenicity of phthalate esters. , 1982, Environmental health perspectives.

[23]  B. Ketterer,et al.  The structure and multiple functions of glutathione transferases. , 1982, Biochemical Society transactions.

[24]  N. Inui.  Mutation, promotion and transformation in vitro , 1981 .

[25]  P. Grasso,et al.  Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man. , 1981, Food and cosmetics toxicology.

[26]  N. Tolbert,et al.  Metabolic pathways in peroxisomes and glyoxysomes. , 1981, Annual review of biochemistry.

[27]  C. Hignite,et al.  HYPOLIPIDEMIC HEPATIC PEROXISOME PROLIFERATORS FORM A NOVEL CLASS OF CHEMICAL CARCINOGENS , 1980 .

[28]  J. Warren,et al.  Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays. , 1980, Cancer research.

[29]  D. Azarnoff,et al.  Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug. , 1979, Cancer research.

[30]  J. Reddy,et al.  Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver. , 1979, Cancer research.

[31]  G. Smith,et al.  Ligandin, the glutathione S-transferases, and chemically induced hepatocarcinogenesis: a review. , 1977, Cancer research.

[32]  R. C. Adelman,et al.  Impaired hormonal regulation of enzyme activity during aging. , 1975, Federation proceedings.

[33]  W B Jakoby,et al.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.

[34]  J. Autian.  Toxicity and health threats of phthalate esters: review of the literature. , 1973, Environmental health perspectives.

[35]  R. Hochschild.  Lysosomes, membranes and aging. , 1971, Experimental gerontology.

[36]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.

[37]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[38]  B. Strehler,et al.  GEE MV: Rate and magnitude of age pigment accumulation in the human myocardium. , 1959, Journal of gerontology.

[39]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[40]  J. M. Patterson,et al.  Lipotropic dose-response studies in rats; comparisons of choline, betaine, and methionine. , 1956, Canadian journal of biochemistry and physiology.

[41]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.